Clinical Trials Directory

Trials / Completed

CompletedNCT02257658

Efficacy of Doxycycline Prophylaxis to Reduce Syphilis in High-Risk, HIV-Positive MSM

Doxycycline Prophylaxis or Incentive Payments to Reduce Incident Syphilis Among HIV- Infected Men Who Have Sex With Men Who Continue to Engage in High Risk Sex: A Randomized, Controlled Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Los Angeles LGBT Center · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

This pilot study will investigate the feasibility of conducting a large, randomized trial comparing a structural intervention to contingency management to reduce incident syphilis infections in an especially high risk group: HIV+ men who have sex with men (MSM) who have had syphilis twice or more since their HIV diagnosis. Subjects will be randomized to receive either QD doxycycline as syphilis prophylaxis or a financial incentive to remain STI free. The investigators will : 1) measure adherence to study visits in both arms; 2) measure adherence to the prophylaxis regimen; 3) measure any changes in risk behaviors among study participants and 4) to the extent possible in a small pilot study of short duration, compare effectiveness of doxycycline with that of a monetary incentive for remaining STI free.

Conditions

Interventions

TypeNameDescription
DRUGDoxycycyline
BEHAVIORALIncentive

Timeline

Start date
2011-09-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2014-10-06
Last updated
2014-10-06

Source: ClinicalTrials.gov record NCT02257658. Inclusion in this directory is not an endorsement.